PATENT CLAIM ANALYSIS

Application Number: 15775647
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "171000"]

Abstract:
Polyethylene glycol (PEG)-conjugated glucocorticoid prodrugs, methods of preparation, and use for the treatment of diseases and disorders are disclosed. In particular, PEG-conjugated dexamethasone compounds and methods of using them for treating inflammatory and autoimmune diseases, including but not limited to lupus, are disclosed.

Claim (Index 3):
The compound of  claim 1 , wherein Z is a linker comprising a branched structure capable of covalently bonding to two or more dexamethasone moieties, said linker optionally comprising one or more heteroatoms independently selected from the group consisting of O, S, and N.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 93.0
- Lexical Diversity: 1.39474
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13837195', '11996009', '14448998', '14670425', '14670422']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7254704836018543
- 35 USC 102 Novelty (BERT): 0.5061362435375301
- Combined Prediction Score: 0.7035370595954219
- Mean Citation Score: 234.029932
- Max Citation Score: 241.24754
- Similarity Product: 151.8068670813846

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test